Genital Diseases, Female  >>  Istodax (romidepsin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Istodax (romidepsin) / Astellas, BMS
NCT00091195: Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer

Terminated
2
51
US
romidepsin, FK228, FR901228, Istodax
National Cancer Institute (NCI)
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
03/07
 

Download Options